Photocure ASA (PHO.OL)

PHO.OL on Oslo Stock Exchange

22.50NOK
10:25am EST
Price Change (% chg)

kr0.50 (+2.27%)
Prev Close
kr22.00
Open
kr22.30
Day's High
kr22.90
Day's Low
kr22.30
Volume
67,515
Avg. Vol
18,762
52-wk High
kr35.20
52-wk Low
kr17.70

PHO.OL

Chart for PHO.OL

About

Photocure ASA is a Norway-based company active in the pharmaceutical industry. It operates in the field of photodynamic diagnosis, cosmetics and treatment of acne, bladder cancer, colon cancer, as well as human papilloma virus (HPV) and precancerous lesions of the cervix. The Company’s activities comprise research, development... (more)
No analyst recommendations are available for PHO.OL.

Overall

Beta: 0.60
Market Cap (Mil.): kr470.65
Shares Outstanding (Mil.): 21.39
Dividend: --
Yield (%): --

Financials

  PHO.OL Industry Sector
P/E (TTM): -- 38.09 39.03
EPS (TTM): -0.11 -- --
ROI: -0.80 17.96 17.31
ROE: -0.80 18.76 18.22
Search Stocks

BRIEF-Photocure Q3 total revenues up to NOK 56.8 million

* Q3 total revenues 56.8 million Norwegian crowns versus 19.2 million crowns

06 Nov 2014

BRIEF-Photocure ASA H1 sales revenues of Hexvix/Cysview NOK 43.2 million

Aug 26 - Photocure ASA : * H1 sales revenues of Hexvix/Cysview NOK 43.2 million versus NOK 35.4 million * Q2 operating loss NOK 5.7 million versus loss NOK 13.9 million * Q2 sales revenues of Hexvix/Cysview NOK 23.8 million versus NOK 20.9 million * Q2 net loss NOK 4.2 million versus loss NOK 15.2 million * Source text for Eikon * Further company coverage

26 Aug 2014

REFILE-BRIEF-Photocure ASA to terminate the global licensing agreement for Lumacan

(Refiles to add a code for Salix Pharmaceuticals ) Aug 18 - Photocure ASA : * Says agreed to terminate the global licensing agreement for Lumacan with Salix Pharmaceuticals * Says Will receive a payment of US$ 5M from Salix and will regain the global rights and all intellectual property to Lumacan. * Source text for Eikon * Further company coverage

18 Aug 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks